We observed previously that DET or DETD-35 treatment could induce the production of reactive oxygen species (ROS) in mouse TS/A mammary cancer cells [9] or human BRAF mutant A375 melanoma cells [18]. The gene discussed is BRAF; the disease is breast cancer.